17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort

PURPOSE: The 17-gene Oncotype DX Genomic Prostate Score (GPS) test predicts adverse pathology (AP) in patients with low-risk prostate cancer treated with immediate surgery. We evaluated the GPS test as a predictor of outcomes in a multicenter active surveillance cohort. MATERIALS AND METHODS: Diagno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Lin, Daniel W., Zheng, Yingye, McKenney, Jesse K., Brown, Marshall D., Lu, Ruixiao, Crager, Michael, Boyer, Hilary, Tretiakova, Maria, Brooks, James D., Dash, Atreya, Fabrizio, Michael D., Gleave, Martin E., Kolb, Suzanne, Liss, Michael, Morgan, Todd M., Thompson, Ian M., Wagner, Andrew A., Tsiatis, Athanasios, Pingitore, Andrea, Nelson, Peter S., Newcomb, Lisa F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2020
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213589/
https://ncbi.nlm.nih.gov/pubmed/32130059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02267
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars